» Articles » PMID: 35531984

ROS Responsive Polyethylenimine-based Fluorinated Polymers for Enhanced Transfection Efficiency and Lower Cytotoxicity

Overview
Specialty General Medicine
Date 2022 May 9
PMID 35531984
Authors
Affiliations
Soon will be listed here.
Abstract

Cationic polymer polyethylenimine (PEI) plays a crucial role in gene delivery. However, high molecular weight PEI leads to higher efficient transfection efficacy and higher cytotoxicity while low molecular weight PEI exhibits lower transfection performance with lower toxicity. Therefore, effective chemical modification of PEI is required to enhance transfection activity and improve biocompatibility. Here, reactive oxygen species (ROS) responsive PEI-based fluorinated polymers (TKPF) with three degrees of fluorination (TKPF12.5%, TKPF25% and TKPF50%) were designed and synthesized by crosslinking low molecular weight PEI (PEI 1.8K) with a thioketal (TK) linker and then modifying heptafluorobutyric anhydride onto their surface. Such gene vectors exhibited the following features: (1) fluorination reduced the positive charge density and endowed hydrophobic and lipophobic characteristics to resist serum interactions; (2) The fluorophilic effect mediated efficient cellular uptake and endosomal escape; (3) ROS-responsive TK linker allowed the polyplex disassembly to decrease the cytotoxicity of the polycations and improve the release of payloads at specific sites. TKPFs attained superior transfection efficiency in multiple cell lines (293TN cells and B16F10 cells) in vitro and showed excellent biocompatibility. Notably, TKPFs also exhibited great serum resistance in gene delivery and TKPF50% transfected nearly 80% cells in the presence of 70% FBS. These results demonstrates that the fluorination and ROS responsiveness combined polycations are excellent gene-delivery vectors with serum-resistant capacity for further application.

Citing Articles

Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies.

Zeng Y, Gao Y, He L, Ge W, Wang X, Ma T Nanoscale Adv. 2024; 6(17):4275-4308.

PMID: 39170969 PMC: 11334973. DOI: 10.1039/d4na00285g.


Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis.

Hua P, Liang R, Yang S, Tu Y, Chen M Bioact Mater. 2024; 36:83-95.

PMID: 38450203 PMC: 10917641. DOI: 10.1016/j.bioactmat.2024.02.030.

References
1.
Deng R, Yue Y, Jin F, Chen Y, Kung H, Lin M . Revisit the complexation of PEI and DNA - how to make low cytotoxic and highly efficient PEI gene transfection non-viral vectors with a controllable chain length and structure?. J Control Release. 2009; 140(1):40-6. DOI: 10.1016/j.jconrel.2009.07.009. View

2.
Francia V, Schiffelers R, Cullis P, Witzigmann D . The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy. Bioconjug Chem. 2020; 31(9):2046-2059. DOI: 10.1021/acs.bioconjchem.0c00366. View

3.
Fang G, Zeng F, Yu C, Wu S . Low molecular weight PEIs modified by hydrazone-based crosslinker and betaine as improved gene carriers. Colloids Surf B Biointerfaces. 2014; 122:472-481. DOI: 10.1016/j.colsurfb.2014.07.007. View

4.
Friedrich M . Gene therapy repair of donor lungs improves outlook for transplantation. JAMA. 2009; 302(23):2530. DOI: 10.1001/jama.302.23.2530. View

5.
Yin H, Kanasty R, Eltoukhy A, Vegas A, Dorkin J, Anderson D . Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014; 15(8):541-55. DOI: 10.1038/nrg3763. View